Clinical trial
Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS
NCT02190149 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS
- Lead sponsor
- Baxalta now part of Shire
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 22, 2014
- Completion date
- March 29, 2016
- Enrollment
- 64 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.